During the last session, Y-Mabs Therapeutics Inc (NASDAQ:YMAB)’s traded shares were 1.07 million, with the beta value of the company hitting 0.66. At the end
Y-Mabs Therapeutics Inc (NASDAQ:YMAB)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting 0.69. At the close of
In last trading session, Y-Mabs Therapeutics Inc (NASDAQ:YMAB) saw 0.76 million shares changing hands with its beta currently measuring 0.69. Company’s recent per share price
Y-Mabs Therapeutics Inc (NASDAQ:YMAB)’s traded shares stood at 0.45 million during the last session, with the company’s beta value hitting 0.63.The YMAB share’s 52-week high
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
